4QBJ
Crystal structure of N-myristoyl transferase from Aspergillus fumigatus complexed with a synthetic inhibitor
Summary for 4QBJ
| Entry DOI | 10.2210/pdb4qbj/pdb |
| Descriptor | Glycylpeptide N-tetradecanoyltransferase, SULFATE ION, S-(2-OXO)PENTADECYLCOA, ... (5 entities in total) |
| Functional Keywords | transferase, myristoyl-coa, myristate translocation, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
| Biological source | Aspergillus fumigatus |
| Cellular location | Cytoplasm: Q9UVX3 |
| Total number of polymer chains | 1 |
| Total formula weight | 47490.08 |
| Authors | Suzuki, M.,Shimada, T. (deposition date: 2014-05-08, release date: 2015-04-01, Last modification date: 2023-11-08) |
| Primary citation | Shimada, T.,Suzuki, M.,Katakura, S. Structure of N-myristoyltransferase from Aspergillus fumigatus Acta Crystallogr.,Sect.D, 71:754-761, 2015 Cited by PubMed Abstract: N-Myristoyltransferase (NMT) is an enzyme which translocates the 14-carbon saturated fatty acid myristate from myristoyl-CoA to the N-terminal glycine of substrate peptides. This myristoylation process is involved in protein modification in various eukaryotes, including animals and fungi. Furthermore, this enzyme has been shown to be essential to the growth of various species, such as Saccharomyces cerevisiae, which indicates that NMT is an attractive target for the development of a novel antifungal drug. In this study, the crystal structure of a ternary complex of NMT from Aspergillus fumigatus with S-(2-oxo)pentadecyl-CoA, a myristoyl-CoA analogue cofactor, and a synthetic inhibitor is reported at a resolution of 2.1 Å. The results advance the understanding of the specificity of NMT inhibitors and provide valuable information for structure-based drug design. PubMed: 25849386DOI: 10.1107/S1399004715000401 PDB entries with the same primary citation |
| Experimental method | X-RAY DIFFRACTION (2.1 Å) |
Structure validation
Download full validation report






